<scp>IĸBζ</scp> as a Central Modulator of Inflammatory Arthritis Pathogenesis
Our study positions IĸBζ as an inflammation-specific target for therapeutic consideration in rheumatoid arthritis because its inhibition spares the beneficial functions of NF-ĸB.
Authors
- Srikanth Singamaneni (ORCID: https://orcid.org/0000-0002-7203-2613)
- Yousef Abu‐Amer (ORCID: https://orcid.org/0000-0002-5890-5086)
- Gaurav Swarnkar (ORCID: https://orcid.org/0000-0001-6052-4971)
- Gabriel Mbalaviele (ORCID: https://orcid.org/0000-0003-4660-0952)
- Prashant Gupta (ORCID: https://orcid.org/0009-0008-6291-9465)
- Musarrat Naaz
- Timothy E. Peterson
- Matthew Christopher
- D. Mims
Institutions
- Washington University in St. Louis (US)
- Shriners Hospitals for Children - St. Louis (US)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1002/art.42990
- Citations
- 2
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Shriners Hospitals for Children
- National Institutes of Health